HLNCF:OTCMKTS
Haleon PLC
4,95 $
arrow_upward
+1,21%(+0,059) 1 p
16. okt, 16:00:00 GMT −4 · USD
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse HLNCF põhistatistika genereerimine…
Ava
4,81 $
Kõrge
4,98 $
Madal
4,81 $
Turu kapit.
44,32 mld
Keskm. maht
10,03 tuh
Maht
17,69 tuh
52 näd kõrgeim
5,75 $
52 näd madalaim
4,15 $
Beeta
−21,47
Käibivad aktsiad
8,80 mld
Töötajate arv
25 tuh
Ava
4,81 $
Kõrge
4,98 $
Madal
4,81 $
Turu kapit.
44,32 mld
Keskm. maht
10,03 tuh
Maht
17,69 tuh
52 näd kõrgeim
5,75 $
52 näd madalaim
4,15 $
Beeta
−21,47
Käibivad aktsiad
8,80 mld
Töötajate arv
25 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
Inshorts
·
31 minuti eest
China's tech index worst-performing globally, down 40% in 6 months | CXMT has fallen 27% from its post-listing peak | Inshorts
KITV
·
26 minuti eest
Nasdaq sinks more than 2% as investors raise questions about AI debt
MarketBeat
·
31 minuti eest
Liberty Global (NASDAQ:LBTYA) Upgraded to Sell at Wall Street Zen
MarketWatch
·
9 tunni eest
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Profiil
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
Teave üksuse Haleon PLC kohta